Evaluation of Galantamine in the Treatment of Alzheimer's Disease
Public ClinicalTrials.gov record NCT00000172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Placebo Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy Under a Slow-Titration Regimen
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Galantamine is an experimental drug being evaluated in the United States for the treatment of Alzheimer's disease. Results from previous clinical trials suggest that galantamine may improve cognitive performance in individuals with Alzheimer's disease. It is not a cure for Alzheimer's disease. Nerve cells in the brain responsible for memory and cognitive function communicate using a chemical called acetylcholine. Research has shown that deterioration of cells that produce acetylcholine in the brain affects thought processes. Galantamine is thought to work in two ways to increase the amount of acetylcholine available in the brain. It inhibits an enzyme that breaks down acetylcholine and it also stimulates the nicotinic receptors in the brain to release more acetylcholine.
Study identification
- NCT ID
- NCT00000172
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 0 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
United States locations
- U.S. sites
- 55
- U.S. states
- 26
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama, Birmingham | Birmingham | Alabama | 35294-0017 | — |
| James L. Frey, M.D., Ltd. | Scottsdale | Arizona | 85258 | — |
| East Bay Neurology | Berkeley | California | 94705 | — |
| University of Southern California | Los Angeles | California | 90033-1039 | — |
| N. County Neurology Assoc. | Oceanside | California | 92056 | — |
| University of California Irvine Medical Center | Orange | California | 92868 | — |
| Pacific Research Network (PRN) | San Diego | California | 92103 | — |
| Affiliated Research Institute | San Diego | California | 92108 | — |
| INC | San Diego | California | 92122 | — |
| The Denver Center for Medical Research | Denver | Colorado | 80212 | — |
| Geriatric and Adult Psychiatry | Hamden | Connecticut | 06518 | — |
| Yale University, School of Medicine | New Haven | Connecticut | 06520 | — |
| Ocala Neurodiagnostic Center | Ocala | Florida | 34471 | — |
| Psychiatric Institute of Florida | Orlando | Florida | 32806 | — |
| Neurological Research Institute of Sarasota, PA | Sarasota | Florida | 34239 | — |
| Suncoast Neuroscience Associates, Inc. | St. Petersburg | Florida | 33701 | — |
| Premiere Research Institute | West Palm Beach | Florida | 33407 | — |
| Chicago Center for Clinical Research | Chicago | Illinois | 606104234 | — |
| OSF Center for Senior Health | Peoria | Illinois | 616033089 | — |
| Indiana Alzheimer's University Clinic | Indianapolis | Indiana | 46202-5111 | — |
| The Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| Brigham Behavioral Neurology Group | Boston | Massachusetts | 02115 | — |
| Boston Clinical Research Center | Wellesley Hills | Massachusetts | 02481 | — |
| University of Massachusetts Worcester | Worcester | Massachusetts | 01655 | — |
| Oakwood Hospital and Medical Center | Dearborn | Michigan | 48124 | — |
| Michigan Medical P.C. | Grand Rapids | Michigan | 49503 | — |
| Regions Hospital | Saint Paul | Minnesota | 55101 | — |
| St. Louis University School of Medicine | St Louis | Missouri | 63104 | — |
| Washington University | St Louis | Missouri | 63108 | — |
| University of Nebraska | Omaha | Nebraska | 681985575 | — |
| University of Medicine and Dentistry of New Jersey | Piscataway | New Jersey | 088551392 | — |
| Neurology Group of Bergen County | Ridgewood | New Jersey | 07450 | — |
| Overlook Hospital | Summit | New Jersey | 07901 | — |
| Medwise Center | West Long Branch | New Jersey | 07764 | — |
| Neurological Associates of Albany, PC | Albany | New York | 12208 | — |
| East End Neuropsychiatric Associates | Centereach | New York | 11720 | — |
| St. John's Episcopal Hospital | Far Rockaway | New York | 11691 | — |
| NYU Medical Center | New York | New York | 10016 | — |
| University of Rochester | Rochester | New York | 14620 | — |
| SUNY Stony Brook | Stony Brook | New York | 11794-8121 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Clinical Pharmaceutical Trials | Tulsa | Oklahoma | 741025428 | — |
| Oregon Health Sciences University | Portland | Oregon | 97201-3098 | — |
| Pacific NW Clinical Research Center | Portland | Oregon | 97201 | — |
| Institute for Advanced Clinical Research | Elkins Park | Pennsylvania | 19027 | — |
| Neuroscience Center of Westmoreland Neurology | Greensburg | Pennsylvania | 15601 | — |
| Brown University | Pawtucket | Rhode Island | 02906 | — |
| Alzheimer's Research and Clinical Programs | North Charleston | South Carolina | 294066076 | — |
| University of Texas | Dallas | Texas | 752359070 | — |
| Southwestern Vermont Medical Center | Bennington | Vermont | 05201 | — |
| Memory Disorder Center of Vermont | Colchester | Vermont | 05446 | — |
| Virginia Neuroscience Center | Alexandria | Virginia | 22304 | — |
| Prince William Neuroscience Center | Manassas | Virginia | 20010 | — |
| Seattle Clinical Research Center | Seattle | Washington | 98104 | — |
| VAPS Health Care System | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00000172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00000172 live on ClinicalTrials.gov.